InvestorsObserver
×
News Home

Should Medical Devices Stock Pulmonx Corp (LUNG) Be in Your Portfolio Friday?

Friday, December 01, 2023 12:23 PM | InvestorsObserver Analysts

Mentioned in this article

Should Medical Devices Stock Pulmonx Corp (LUNG) Be in Your Portfolio Friday?

A rating of 77 puts Pulmonx Corp (LUNG) near the top of the Medical Devices industry according to InvestorsObserver. Pulmonx Corp's score of 77 means it scores higher than 77% of stocks in the industry. Pulmonx Corp also received an overall rating of 54, putting it above 54% of all stocks. Medical Devices is ranked 82 out of the 148 industries.

Overall Score - 54
LUNG has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on LUNG!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Pulmonx Corp Stock Today?

Pulmonx Corp (LUNG) stock is trading at $11.01 as of 12:04 PM on Friday, Dec 1, a rise of $0.11, or 1.01% from the previous closing price of $10.90. Volume today is high. So far 460,356 shares have traded compared to average volume of 261,328 shares. The stock has traded between $10.30 and $11.06 so far today. Click Here to get the full Stock Report for Pulmonx Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App